New developments in gene editing for Duchenne muscular dystrophy

Nature Reviews Cardiology, Published online: 11 February 2020; doi:10.1038/s41569-020-0350-7A somatic gene editing therapy for the treatment of Duchenne muscular dystrophy (DMD) improves skeletal and cardiac muscle function and reduces cardiac arrhythmogenic vulnerability in a pig model of DMD and an in vitro model of human DMD.

http://feeds.nature.com/~r/nrcardio/rss/current/~3/Cn-aMv1O5gU/s41569-020-0350-7

Source: Nature Reviews Cardiology - February 10, 2020 Category: Cardiology Authors: Irene Fern ández-Ruiz Source Type: research

More News: Cardiology | Genetics | Heart | Muscular Dystrophy | Reflex Sympathetic Dystrophy